Nasal spray for anxiety in palliative care
Treatments studied
Part of Mental health clinical trials.
This trial tests a nasal spray called midazolam to quickly reduce anxiety in people receiving palliative care. If you're an adult in the hospital with sudden anxiety, this could help you feel calmer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and getting palliative care in the hospital.
- You have sudden anxiety that your doctor thinks needs treatment with a nasal spray.
- You can fill out a short questionnaire about your anxiety.
- You are able to sign a consent form.
- You haven't had this nasal spray in the last 24 hours.
- You are not taking certain other medicines that could interact.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a low dose of ketamine nasal spray can help reduce depression and anxiety in people living with advanced cancer. If you have a progressive cancer and are feeling down or anxious, you might benefit from this quick treatment.
This trial tests three medicines given through the nose to keep children comfortable during minor procedures in the emergency department, specifically for closing small cuts with stitches. It may help find which nasal medicine works best and is safest for quick, minimal procedures.
This trial tests whether taking a medicine called midazolam before surgery can help with pain after surgery in people with colorectal cancer who have trouble sleeping or feel anxious. You would receive the medicine as a drink before your operation.
This study tests whether a medication called dexmedetomidine, given as a nasal spray, can quickly relieve sudden anxiety. The goal is to see if this approach works better or faster than current treatments for acute anxiety episodes.
This study tests if a new nasal spray called fasedienol helps quickly reduce anxiety in adults with social anxiety disorder. The spray is used as needed in a repeat-dose design, meaning you might use it more than once.
This trial tests if giving a sedative (midazolam) as a nose spray can help reduce pain and stress in premature babies during a routine eye exam for retinopathy of prematurity. It aims to make the exam more comfortable for babies.
Hear when a new Anxiety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.